These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

831 related items for PubMed ID: 23773638

  • 1. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
    Zhu T, Feng L.
    Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH, Nurdayana AK, Rusni D, Azwany Y.
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [Abstract] [Full Text] [Related]

  • 4. [Value of four serum markers in the diagnosis of rheumatoid arthritis].
    Zhang X, Jiang L, Zhang X, Guo Y, Shen T, Wang X.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):538-41. PubMed ID: 23644115
    [Abstract] [Full Text] [Related]

  • 5. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
    Galati S, Beauvillain C, Renier G, Jeannin P, Masson C, Chevailler A.
    Ann Biol Clin (Paris); 2008 Apr; 66(2):157-64. PubMed ID: 18390426
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R, Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators.
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F.
    J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
    [Abstract] [Full Text] [Related]

  • 10. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis].
    Xie QB, Yin G.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O, Martinez-Gamboa L, Egerer K, Bang H, Fredenhagen G, Roggenbuck D, Esaulenko I, Burmester GR, Chernykh T, Feist E.
    Clin Exp Rheumatol; 2014 May; 32(5):622-9. PubMed ID: 25189876
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A, Plischke H, Kellner H, Gruber R.
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [Abstract] [Full Text] [Related]

  • 15. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
    Svärd A, Kastbom A, Söderlin MK, Reckner-Olsson Å, Skogh T.
    J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
    Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M.
    Arthritis Res Ther; 2006 Jul; 8(4):R119. PubMed ID: 16859519
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.
    Keskin G, Inal A, Keskin D, Pekel A, Baysal O, Dizer U, Sengül A.
    Protein Pept Lett; 2008 Jul; 15(3):314-7. PubMed ID: 18336364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.